Background: Discordance between fractional flow reserve (FFR) and nonhyperemic pressure ratios (NHPRs) can occur in about 20% of clinical cases, creating treatment dilemmas in the cardiac catheterization laboratory.
Objectives: The authors sought to perform a systematic review and meta-analyses investigating the long-term outcome of deferral strategy in patients found to have discordant physiology.
Methods: The primary comparison tested the long-term prognosis of patients who were deferred for discordant physiology vs those deferred for concordant negative results. Various NHPRs were compared with FFR. The primary endpoint was a composite of death (all-cause or cardiac) and myocardial infarction/revascularization with several definitions. Secondary endpoint consisted of death or myocardial infarction. The study is registered with PROSPERO (CRD42024628393).
Results: Six eligible trials with 9,854 intermediate lesions deferred for PCI were considered in the analysis. Compared with concordant-negative physiology (FFR-/NHPRs-), deferral of PCI for discordant physiology was associated with an increase in the primary endpoints (FFR-/NHPRs+: HR: 2.73 [1.95-3.80]; P < 0.00001 and FFR+/NHPRs-: HR: 3.29[2.33-4.64]; P < 0.00001). Secondary dichotomous analysis showed that deferral of PCI in both discordant groups was associated with an increase in the hard endpoints (death or myocardial infarction) compared with concordant-negative physiology. Exploratory analysis comparing revascularization vs deferral groups within discordant physiology demonstrated reduction in the primary endpoint in the FFR+/NHPRs- group, but not in the FFR-/NHPRs+ group.
Conclusions: Deferral of PCI in discordant-physiology was associated with worse long-term outcomes compared with the concordant-negative physiology. There may be a benefit of revascularization in FFR+/NHPRs- lesions, which requires further investigation.
Keywords: FFR; deferral of PCI; discordant physiology; fractional flow reserve; iFR; nonhyperemic pressure ratios.
Copyright © 2025 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.